Materials Today Bio · 2023 · 42 citations · 30 references
PharmacyImmunologyOncologyCancer ImmunologyDrug DeliveryImmunotherapyCancer ImmunotherapyCancer VaccinesLiposome-based DeliveryTherapeutic VaccinesVaccine DeliveryVaccine PlatformsAntitumor Immune ActivationCancer Vaccine Delivery SystemsExtracellular Vesicle-mediated ImmunomodulationExtracellular VesiclesImmune Modulation By Extracellular VesiclesPd-l1 BlockadePreventive VaccinationProphylactic Cancer Vaccines
Combination immunotherapy of cancer vaccines with immune checkpoint inhibitors (ICIs) represents a promising therapeutic strategy for immunosuppressed and cold tumors. However, this strategy still faces challenges, including the limited therapeutic efficacy of cancer vaccines and immune-related adverse events associated with systematic delivery of ICIs. Herein, we demonstrate the antitumor immune response induced by outer membrane vesicle from Akkermansia muciniphila (Akk-OMV), which exhibites a favorable safety profile, highlighting the potential application as a natural and biocompatible self-adjuvanting vesicle. Utilizing tumor cell-derived exosome as an antigen source and Akk-OMV as a natural adjuvant, we construct a cancer vaccine formulation of extracellular vesicles hybrid lipid nanovesicles (Lipo@HEV) for enhanced prophylactic and therapeutic vaccination by promoting dendritic cell (DC) maturation in lymph node and activating cytotoxic T cell (CTL) response. The Lipo@HEV is further loaded with plasmid to enable gene therapy-mediated PD-L1 blockade upon peritumoral injection. Meanwhile, it penetrates into lymph node to initiate DC maturation and CTL activation, synergistically inhibiting the established tumor. The fabrication of extracellular vesicles hybrid plasmid-loaded lipid nanovesicles reveals a promising gene therapy-guided and vesicle-based hybrid system for therapeutic cancer vaccination and synergistic immunotherapy strategy.
30
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa et al. · Science · 2017 · 5.4K citations
Life Sciences, Immunology, Oncology +17
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
Vyara Matson, Jessica Fessler, Riyue Bao et al. · Science · 2018 · 3K citations
Life Sciences, Immunology, Oncology +17
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott, Zhuting Hu, Derin B. Keskin et al. · Nature · 2017 · 2.9K citations
Medicine, Immunology, Oncology +12
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Sushrut Kamerkar, Valerie S. LeBleu, Hikaru Sugimoto et al. · Nature · 2017 · 2.6K citations
Medicine, Cancer Biology, Oncology +13